Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

被引:0
|
作者
Toshie Manabe
Dan Kambayashi
Hiroyasu Akatsu
Koichiro Kudo
机构
[1] Nagoya City University Graduate School of Medicine,
[2] Nagoya City University West Medical Center,undefined
[3] Showa Pharmaceutical University,undefined
[4] Yurin Hospital,undefined
[5] Waseda University Regional and Inter-Regional Organization,undefined
来源
关键词
Favipiravir; COVID-19; SARS-CoV-2; Viral clearance; Clinical improvement;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
    Manabe, Toshie
    Kambayashi, Dan
    Akatsu, Hiroyasu
    Kudo, Koichiro
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [2] Favipiravir for the Treatment of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Naveed, Aiman
    Cheema, Huzaifa Ahmad
    Shahid, Abia
    Umer, Mohammad
    ul Hussain, Hassan
    Rehman, Mohammad Ebad Ur
    Singh, Harpreet
    Kurman, Jonathan S.
    Sahra, Syeda
    Ahmad, Faran
    Ahmad, Sharjeel
    Iqbal, Sana
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (04) : e478 - e482
  • [3] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Hassanipour, Soheil
    Arab-Zozani, Morteza
    Amani, Bahman
    Heidarzad, Forough
    Fathalipour, Mohammad
    Martinez-de-Hoyo, Rudolph
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Soheil Hassanipour
    Morteza Arab-Zozani
    Bahman Amani
    Forough Heidarzad
    Mohammad Fathalipour
    Rudolph Martinez-de-Hoyo
    Scientific Reports, 11
  • [5] Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Lan, Shao-Huan
    Lai, Chih-Cheng
    Chang, Shen-Peng
    Lu, Li-Chin
    Hung, Shun-Hsing
    Lin, Wei-Ting
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (06) : 759 - 766
  • [6] Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
    Wei, Qiu
    Lin, Hua
    Wei, Rong-Guo
    Chen, Nian
    He, Fan
    Zou, Dong-Hua
    Wei, Jin-Ru
    INFECTIOUS DISEASES OF POVERTY, 2021, 10 (01)
  • [7] Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
    Karolina Dahms
    Agata Mikolajewska
    Kelly Ansems
    Maria-Inti Metzendorf
    Carina Benstoem
    Miriam Stegemann
    European Journal of Medical Research, 28
  • [8] Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
    Qiu Wei
    Hua Lin
    Rong-Guo Wei
    Nian Chen
    Fan He
    Dong-Hua Zou
    Jin-Ru Wei
    Infectious Diseases of Poverty, 10
  • [9] Quercetin for the treatment of COVID-19 patients: A systematic review and meta-analysis
    Cheema, Huzaifa Ahmad
    Sohail, Aruba
    Fatima, Areej
    Shahid, Abia
    Shahzil, Muhammad
    Rehman, Mohammad Ebad Ur
    Awan, Rehmat Ullah
    Chinnam, Sampath
    Nashwan, Abdulqadir J.
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (02)
  • [10] Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
    Dahms, Karolina
    Mikolajewska, Agata
    Ansems, Kelly
    Metzendorf, Maria-Inti
    Benstoem, Carina
    Stegemann, Miriam
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)